A weekly publication by the Bureau of Epidemiology
June 29, 2001
"The reason for collecting, analyzing and disseminating information on a disease is to control that disease. Collection and analysis should not be allowed to consume resources if action does not follow."
--Foege WH et al. Int. J of Epidemiology 1976; 5:29-37.
Richard S. Hopkins, MD, MSPH, Bureau Chief, State Epidemiologist
Don Ward, Surveillance Section Administrator, Epi Update Managing Editor
Jason Glisson, BS, Epi Editorial Assistant
Bureau of Epidemiology Frequent Contributors:
|
Steven Wiersma, MD, MPH, Deputy State Epidemiologist |
Jodi Baldy, MPH, Biological Scientist IV |
|
Ursula E. Bauer, PhD, Chronic Disease Epidemiologist |
Lisa Conti, DVM, MPH, State Public Health Veterinarian |
Regional Epidemiologists:
|
Dolly Katz, PhD, MPH, SE Florida |
Roger Sanderson, RN, MA, SW Florida |
Carina Blackmore, MS Vet. Med., PhD, NE Florida |
Zuber Mulla, MSPH, Central Florida Carina Blackmore, MS Vet. Med., PhD, |
Please print out this material and share with epidemiology staff, county health department directors, administrators, medical directors, nursing directors, environmental health directors and others with an interest in information of this type. Thank you.
The Bureau of Epidemiology is available 24 hours a day, 7 days a week for consultation at our main number (SunCom 205-4401 or 850/245-4401) PLEASE NOTE: Consultation after 5 p.m. & on weekends is intended for emergencies.
The Department of Health has a home on the World Wide Web at
http://www.doh.state.fl.usIn this issue:
1. Update on the Counties’ Use of Program Code 09 Hepatitis Vaccine and Laboratory Testing for High Risk Adults
Sandy Roush, MT, MPH. Director, Division of Disease Control
In December, 2000, seventeen counties began a pilot project addressing the need for hepatitis A and hepatitis B vaccine for adults at increased risk for hepatitis or its adverse consequences. The project also addresses the need for laboratory testing for chronic hepatitis B and hepatitis C infections (HBsAg, HBsAb, HBcAb, HCV antibody, and HCV confirmatory testing) among high risk adults.
On March 12, 2001, the Bureau of Epidemiology, Florida Hepatitis and Liver Failure Prevention and Control Program (HLFPCP), expanded the program to make hepatitis vaccine and laboratory testing available at no cost to all Florida counties, except those currently receiving funding through the HLFPCP budget (Broward, Miami-Dade, Collier, Monroe, Polk, and Pinellas). The vaccines and laboratory testing are available at no cost to the counties for high risk adults, following the guidelines given on the attached memo from Dr. Landis Crockett.
As of May 22, 2001, 23 counties have ordered hepatitis A and/or hepatitis B vaccine through this program. Also, as of that date, 17 counties have used the laboratory testing available through the 09 program code. Maps showing the participating counties are attached to this update.
If you have any questions about this project, or about any other aspects of the Hepatitis Program, please contact Sandy Roush, M.T., M.P.H., Head, Hepatitis and Liver Failure Prevention and Control Program, at (850) 245-4444, extension 2410 or SC 205-4444, extension 2410 or by e-mail at sandra_roush@doh.state.fl.us.
2. Weekly Disease Table (Week 25)
| DISEASE |
1999 TO |
2000 TO |
3-YEAR |
2000 |
2001 TO |
2001 |
|
Animal Rabies |
78 |
63 |
79 |
161 |
98 |
0 |
|
Anthrax |
0 |
0 |
0 |
0 |
0 |
0 |
|
Botulism, foodborne |
0 |
0 |
0 |
0 |
0 |
0 |
|
Botulism, infant |
0 |
0 |
0 |
0 |
0 |
0 |
|
Botulism, wound |
0 |
0 |
0 |
0 |
0 |
0 |
|
Botulism, other |
0 |
0 |
0 |
0 |
0 |
0 |
|
Brucellosis |
0 |
1 |
0.7 |
2 |
1 |
0 |
|
Campylobacteriosis |
385 |
379 |
356.3 |
1026 |
347 |
20 |
|
Ciguatera |
1 |
0 |
2.3 |
14 |
0 |
0 |
|
Cryptosporidiosis |
49 |
20 |
39 |
180 |
36 |
1 |
|
Cyclosporiasis |
2 |
2 |
2.7 |
9 |
21 |
0 |
|
Dengue Fever |
2 |
0 |
1 |
3 |
3 |
0 |
|
Diphtheria |
0 |
0 |
0 |
0 |
0 |
0 |
|
Ehrlichiosis, human |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, chickenpox |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, Eastern Equine |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, herpes |
2 |
3 |
2.7 |
7 |
1 |
0 |
|
Encephalitis, influenza |
0 |
1 |
0.3 |
1 |
0 |
0 |
|
Encephalitis, measles |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, mumps |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, other |
3 |
4 |
3.7 |
8 |
2 |
0 |
|
Encephalitis, St. Louis |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, Venezuelan |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, Western Equine |
0 |
0 |
0 |
0 |
0 |
0 |
|
Escherichia Coli 0157:H7 |
14 |
18 |
14 |
95 |
9 |
1 |
|
Escherichia Coli, other |
10 |
5 |
5.7 |
13 |
4 |
0 |
|
Giardiasis |
417 |
454 |
462 |
1466 |
409 |
25 |
|
H. Influenzae Cellulitis |
0 |
0 |
0.7 |
1 |
0 |
0 |
|
H. Influenzae Epiglottitis |
0 |
0 |
0 |
1 |
0 |
0 |
|
H. Influenzae Meningitis |
10 |
1 |
6 |
11 |
4 |
0 |
|
H. Influenzae Pneumonia |
2 |
2 |
2.3 |
7 |
12 |
0 |
|
H. Influenzae Prim.Bacteremia |
11 |
18 |
12.3 |
57 |
42 |
1 |
|
H. Influenzae Septic Arthritis |
0 |
0 |
0 |
1 |
0 |
0 |
|
Hantaviris Infection |
0 |
0 |
0 |
0 |
0 |
0 |
|
Hemolytic Uremic Syndrome |
2 |
5 |
3 |
18 |
1 |
0 |
|
Hemorrhagic Fever |
0 |
0 |
0 |
0 |
0 |
0 |
|
Hepatitis A |
296 |
218 |
253.3 |
589 |
246 |
19 |
|
Hepatitis B |
180 |
191 |
180.7 |
525 |
181 |
11 |
|
Hepatitis B (+HbsAg in pregnant women) |
5 |
177 |
60.7 |
493 |
164 |
12 |
|
Hepatitis, Perinatal Hep B |
1 |
1 |
0.7 |
1 |
4 |
0 |
|
Hepatitis C |
22 |
8 |
10 |
19 |
11 |
1 |
|
Hepatitis, Non-A, Non-B |
1 |
4 |
15 |
6 |
1 |
0 |
|
Hepatitis, Other, including unspecified |
9 |
6 |
6.7 |
7 |
4 |
0 |
|
Lead Poisoning |
719 |
490 |
648 |
1219 |
297 |
29 |
|
Legionellosis |
9 |
20 |
16 |
51 |
24 |
1 |
|
Leprosy |
2 |
0 |
1.7 |
4 |
0 |
0 |
|
Leptospirosis |
0 |
1 |
0.3 |
2 |
0 |
0 |
|
Listeriosis |
9 |
12 |
7 |
32 |
8 |
0 |
|
Lyme Disease |
6 |
8 |
9.3 |
54 |
6 |
0 |
|
Malaria |
37 |
37 |
32.3 |
90 |
22 |
0 |
|
Measles |
1 |
0 |
1 |
2 |
0 |
0 |
|
Meningitis, Group B Strep |
6 |
7 |
7 |
21 |
5 |
0 |
|
Meningitis, List Monocytogenes |
4 |
1 |
3 |
7 |
0 |
0 |
|
Meningitis, Meningococcal |
23 |
15 |
20.3 |
41 |
30 |
1 |
|
Meningitis, other |
22 |
44 |
30.7 |
110 |
37 |
4 |
|
Meningitis, Strep Pneumoniae |
60 |
52 |
54.3 |
112 |
34 |
0 |
|
Meningococcemia, disseminated |
33 |
39 |
38 |
80 |
34 |
0 |
|
Mercury Poisoning |
2 |
3 |
1.7 |
11 |
2 |
0 |
|
Mumps |
2 |
2 |
4.3 |
4 |
1 |
0 |
|
Neurotoxic Shellfish Poisoning |
0 |
0 |
0 |
0 |
0 |
0 |
|
Pertussis |
23 |
24 |
21.7 |
48 |
7 |
0 |
|
Plague, Bubonic |
0 |
0 |
0 |
0 |
0 |
0 |
|
Plague, Pneumonic |
0 |
0 |
0 |
0 |
0 |
0 |
|
Poliomyelitis |
0 |
0 |
0 |
0 |
0 |
0 |
|
Psittacosis |
0 |
0 |
0.3 |
3 |
0 |
0 |
|
Q Fever |
0 |
0 |
0 |
0 |
0 |
0 |
|
Human Rabies |
0 |
0 |
0 |
0 |
0 |
0 |
|
Rocky Mountain Spotted Fever |
1 |
0 |
0.7 |
1 |
1 |
0 |
|
Rubella |
0 |
2 |
1.7 |
2 |
1 |
0 |
|
Rubella, Congenital |
0 |
0 |
0 |
1 |
0 |
0 |
|
Salmonellosis |
838 |
718 |
757.3 |
2755 |
811 |
48 |
|
Shigellosis |
635 |
541 |
654.7 |
1292 |
329 |
19 |
|
Smallpox |
0 |
0 |
0 |
0 |
0 |
0 |
|
Staphylococcus Aureus (GISA/VISA) |
0 |
0 |
0 |
0 |
1 |
0 |
|
Staphylococcus Aureus (GRSA/VRSA) |
0 |
0 |
0 |
0 |
1 |
0 |
|
Streptococcal Disease, Invasive Group A |
25 |
64 |
38 |
146 |
79 |
1 |
|
Streptococcus Pneumoniae, Invasive |
278 |
512 |
349 |
1147 |
494 |
9 |
|
Tetanus |
1 |
0 |
1 |
1 |
2 |
0 |
|
Toxoplasmosis |
4 |
6 |
5.3 |
12 |
7 |
0 |
|
Trichinosis |
0 |
0 |
0 |
1 |
0 |
0 |
|
Tularemia |
0 |
0 |
0 |
0 |
0 |
0 |
|
Typhoid Fever |
20 |
5 |
11 |
12 |
3 |
0 |
|
Vibrio Alginolyticus |
5 |
3 |
3 |
15 |
1 |
0 |
|
Vibrio Cholerae Type 01 |
0 |
0 |
0 |
0 |
0 |
0 |
|
Vibrio Cholerae Non-01 |
4 |
3 |
3.7 |
4 |
3 |
0 |
|
Vibrio Fluvialis |
2 |
0 |
1.7 |
2 |
0 |
0 |
|
Vibrio Hollisae |
4 |
3 |
3 |
3 |
0 |
0 |
|
Vibrio Mimicus |
1 |
2 |
2 |
2 |
1 |
1 |
|
Vibrio, other |
1 |
0 |
0.7 |
2 |
0 |
0 |
|
Vibrio Parahaemolyticus |
6 |
3 |
6.7 |
16 |
3 |
0 |
|
Vibrio Vulnificus |
4 |
1 |
3.7 |
13 |
3 |
0 |
|
Yellow Fever |
0 |
0 |
0 |
0 |
0 |
0 |